Background Background It is essential in economic
It is essential in economic evaluations of schizophrenia interventions evaluations of schizophrenia interventions that all relevant costs are identified and that all relevant costs are identified and measured appropriately. Also of measured appropriately. Also of importance is the way in which cost data importance is the way in which cost data are combined with information on are combined with information on outcomes. outcomes.
Aims Aims To examine the use of health
To examine the use of health economics in evaluations of interventions economics in evaluations of interventions for schizophrenia. for schizophrenia.
Methods Methods A review of the key methods
A review of the key methods used to estimate costs and to linkcosts and used to estimate costs and to linkcosts and outcomes was conducted. outcomes was conducted.
Results

Results Costs fall on a number of
Costs fall on a number of different agencies and can be shortterm different agencies and can be shortterm or long term.Cost-effectiveness analysis or long term.Cost-effectiveness analysis and cost^utility analysis are the most and cost^utility analysis are the most appropriate methods for combing cost and appropriate methods forcombing cost and outcome data. outcome data.
Conclusions Conclusions Schizophrenia poses a
Schizophrenia poses a number of challenges for economic number of challenges for economic evaluation. evaluation.
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In evaluating interventions to treat schizoIn evaluating interventions to treat schizophrenia it is clearly important to assess phrenia it is clearly important to assess the clinical and social effects of the interthe clinical and social effects of the intervention and to measure these appropriately. vention and to measure these appropriately. It will often be desirable to include a numIt will often be desirable to include a number of outcome measures, ranging from ber of outcome measures, ranging from those with a relatively narrow perspective those with a relatively narrow perspective (e.g. symptom measures) to those which (e.g. symptom measures) to those which are more holistic (e.g. quality of life meaare more holistic (e.g. quality of life measures). Ideally, we would hope that decision sures). Ideally, we would hope that decision makers would only favour interventions makers would only favour interventions which have proven efficacy. Although good which have proven efficacy. Although good evidence is certainly required for new treatevidence is certainly required for new treatments or services, some of those in exisments or services, some of those in existence probably do not have as firm an tence probably do not have as firm an evidence base. evidence base.
Evidence that an intervention is effecEvidence that an intervention is effective does not in itself mean that it should tive does not in itself mean that it should be implemented. All interventions require be implemented. All interventions require the use of resources (money, time, equipthe use of resources (money, time, equipment, etc.) , and these will inevitably be limment, etc.), and these will inevitably be limited in their supply and able to be used to ited in their supply and able to be used to provide care in other ways (whether for provide care in other ways (whether for people with schizophrenia or with asthma, people with schizophrenia or with asthma, cancer, etc.). Resource scarcity and competcancer, etc.). Resource scarcity and competing demands for these resources means that ing demands for these resources means that the costs of interventions for schizophrenia the costs of interventions for schizophrenia need to be assessed in addition to outcomes. need to be assessed in addition to outcomes.
MEASURING COSTS MEASURING COSTS
Costs occur when a productive activity Costs occur when a productive activity takes place that necessitates the use of takes place that necessitates the use of scarce resources that could be used for scarce resources that could be used for some other purpose. Economists describe some other purpose. Economists describe this as an opportunity cost. The time that this as an opportunity cost. The time that psychiatrists, community mental health psychiatrists, community mental health nurses, psychologists, social workers and nurses, psychologists, social workers and others spend in providing care for people others spend in providing care for people with schizophrenia could be spent with with schizophrenia could be spent with other patient groups, and hence a cost other patient groups, and hence a cost arises. Unpaid care (from families/friends) arises. Unpaid care (from families/friends) will also frequently be used, and this also will also frequently be used, and this also has an opportunity cost. has an opportunity cost.
The focus of economic analyses is often The focus of economic analyses is often on the final figure (in pounds, dollars, on the final figure (in pounds, dollars, euros, etc.), but this is simply a proxy euros, etc.), but this is simply a proxy measure for care inputs (and in schizomeasure for care inputs (and in schizophrenia these will be many) that a patient phrenia these will be many) that a patient receives. It is generally incorrect to regard receives. It is generally incorrect to regard costs as outcomes; rather they are a reprecosts as outcomes; rather they are a representation of inputs that produce outcomes. sentation of inputs that produce outcomes. Some of the impacts of interventions for Some of the impacts of interventions for schizophrenia can be measured in monetary schizophrenia can be measured in monetary units, for example in-patient admissions, if units, for example in-patient admissions, if a reduction is the main aim of the intervena reduction is the main aim of the intervention, as with crisis resolution teams. tion, as with crisis resolution teams.
To estimate the cost of schizophrenia To estimate the cost of schizophrenia care it is necessary to identify all the recare it is necessary to identify all the resources required to provide this care and sources required to provide this care and also those resources that are subsequently also those resources that are subsequently affected. The costs of treatment with atypiaffected. The costs of treatment with atypical antipsychotics, for example, include not cal antipsychotics, for example, include not only the specific drug costs but also the proonly the specific drug costs but also the professional time required to administer and fessional time required to administer and monitor treatment plus the cost of other monitor treatment plus the cost of other care (such as in-patient stays and outcare (such as in-patient stays and outpatient appointments) if these may change patient appointments) if these may change as a result of the drug treatment. as a result of the drug treatment.
A common costing perspective in eco-A common costing perspective in economic evaluations is to include all health nomic evaluations is to include all health service costs. This is the preferred view of service costs. This is the preferred view of the UK's National Institute for Health and the UK's National Institute for Health and Clinical Excellence (NICE), whose remit is Clinical Excellence (NICE), whose remit is to offer guidance on the spending of Nato offer guidance on the spending of National Health Service finances. In schizotional Health Service finances. In schizophrenia care even this will be inadequate, phrenia care even this will be inadequate, as interventions which are successful (e.g. as interventions which are successful (e.g. in reducing positive symptoms) could alter in reducing positive symptoms) could alter the use a patient makes of social care, eduthe use a patient makes of social care, education and criminal justice services. Costs cation and criminal justice services. Costs to families and friends in terms of the to families and friends in terms of the unpaid care (but representing costly lost unpaid care (but representing costly lost opportunities) provided and also the potenopportunities) provided and also the potential value of patient time spent in contact tial value of patient time spent in contact with services could also be included. with services could also be included.
The Client Service Receipt Inventory The Client Service Receipt Inventory (CSRI; ) is the (CSRI; ) is the most commonly used questionnaire to meamost commonly used questionnaire to measure service costs for people with schizosure service costs for people with schizophrenia. The CSRI is usually completed phrenia. The CSRI is usually completed through interviews with patients, although through interviews with patients, although case notes and information from carers case notes and information from carers can be used, and some versions can be can be used, and some versions can be completed by the patients themselves. The completed by the patients themselves. The information collected with the CSRI, or a information collected with the CSRI, or a similar measure, can be combined with similar measure, can be combined with appropriate unit cost information (e.g. appropriate unit cost information (e.g. Curtis & Netten, 2006) 
Costing systems of care Costing systems of care
Several studies have assessed the economic Several studies have assessed the economic impact of alternative approaches to deliverimpact of alternative approaches to delivering schizophrenia care. In a review of ing schizophrenia care. In a review of home-based care (assertive community home-based care (assertive community s 4 2 s 4 2
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( 2 0 0 7 ) , 1 9 1 ( s u p p l . 5 0 ) , s 4 2^s 4 5 . d o i : 1 0 .11 9 2 / b j p .1 9 1 . 5 0 . s 4 2 ( 2 0 0 7 ) , 1 9 1 ( s u p p l . 5 0 ) , s 4 2^s 4 5 . d o i : 1 0 .11 9 2 / b j p .1 9 1 . 5 0 . s 4 2 treatment and crisis interventions) Burns treatment and crisis interventions) Burns et et al al (2001) identified 22 studies that had (2001) identified 22 studies that had included an economic component. It was included an economic component. It was encouraging that many of these did take a encouraging that many of these did take a relatively comprehensive approach to costrelatively comprehensive approach to costing and that this had improved compared ing and that this had improved compared with an earlier review (McCrone & Weich, with an earlier review (McCrone & Weich, 1996 ). 1996 .
Broader studies have attempted to cost Broader studies have attempted to cost the impact of schizophrenia at a national the impact of schizophrenia at a national and even international level. Making and even international level. Making comparisons between countries presents comparisons between countries presents difficulties given variations in the methoddifficulties given variations in the methodologies used (Andlin-Sobocki & Rossler, ologies used (Andlin-Sobocki & Rö ssler, 2005) . Differences in price levels generally 2005). Differences in price levels generally (and healthcare prices in particular), the (and healthcare prices in particular), the supply of specific services and the structure supply of specific services and the structure of mental health services will all affect of mental health services will all affect service costs, as will variations in patient service costs, as will variations in patient need. Nevertheless, it can still be informaneed. Nevertheless, it can still be informative to examine the contribution that specitive to examine the contribution that specific services make to overall service costs. fic services make to overall service costs.
In-patient care has consistently been the In-patient care has consistently been the most costly service since deinstitutionalisamost costly service since deinstitutionalisation began. Knapp tion began. Knapp et al et al (2004) reported (2004) reported that it accounts for between 28 and 94% that it accounts for between 28 and 94% of direct healthcare costs in schizophrenia, of direct healthcare costs in schizophrenia, whereas medication usually accounts for whereas medication usually accounts for less than 15% of costs. One exception less than 15% of costs. One exception was in Nigeria where medication accounted was in Nigeria where medication accounted for 62% of costs, reflecting the much for 62% of costs, reflecting the much higher drug costs relative to cost of inhigher drug costs relative to cost of inpatient care in low-and middle-income patient care in low-and middle-income countries. This is a vivid reminder that cost countries. This is a vivid reminder that cost findings in one area cannot be simply transfindings in one area cannot be simply translated to another. The supply of services will lated to another. The supply of services will naturally have a major impact on utilisanaturally have a major impact on utilisation and therefore costs. In a five-country tion and therefore costs. In a five-country comparison of schizophrenia care (Table  comparison of schizophrenia care (Table  1) costs were particularly low in a Spanish 1) costs were particularly low in a Spanish city where there was limited availability of city where there was limited availability of day or residential care (Knapp day or residential care (Knapp et al et al, 2002) . , 2002).
Costs of specific interventions Costs of specific interventions
Economic evaluations have been conducted Economic evaluations have been conducted of a wide range of interventions for schizoof a wide range of interventions for schizophrenia (McCrone & Weich, 1996; Byford phrenia (McCrone & Weich, 1996; Byford et al et al, 2003) . Most tend to concentrate on , 2003). Most tend to concentrate on healthcare costs, with some also including healthcare costs, with some also including social care and criminal justice service social care and criminal justice service costs. Very few evaluations have assessed costs. Very few evaluations have assessed the impact that interventions have on the impact that interventions have on informal care costs, an important omission informal care costs, an important omission as many community-based interventions as many community-based interventions could well increase the necessity for care could well increase the necessity for care from family members or friends. from family members or friends.
Another neglected cost is patient time Another neglected cost is patient time spent using services. In economics spent using services. In economics generally, time is valued using information generally, time is valued using information on an individual's wages, but the majority on an individual's wages, but the majority of patients in contact with specialist serof patients in contact with specialist services are not in work. However, this does vices are not in work. However, this does not mean that the value of time is zeronot mean that the value of time is zerotime spent on other activities will still have time spent on other activities will still have to be forgone in order to use services. This to be forgone in order to use services. This might be relevant when evaluating assertive might be relevant when evaluating assertive community treatment, which is principally community treatment, which is principally targeted at patients who are 'difficult to targeted at patients who are 'difficult to engage'. Although it is probable that engage'. Although it is probable that engagement problems are usually a result engagement problems are usually a result of the clinical features of schizophrenia, of the clinical features of schizophrenia, some patients might be engaged in other some patients might be engaged in other activities that they value and which limit activities that they value and which limit the time which they wish to spend the time which they wish to spend accessing services (even if this is to the accessing services (even if this is to the detriment of their mental health). detriment of their mental health).
Cost information is also relatively Cost information is also relatively limited concerning the period before limited concerning the period before patients receive care for schizophrenia. patients receive care for schizophrenia. The duration of untreated psychosis The duration of untreated psychosis (DUP) has been reported to be up to 1-2 (DUP) has been reported to be up to 1-2 years (McGlashan, 1999) . Case-note narrayears (McGlashan, 1999) . Case-note narratives and studies of pathways into care tives and studies of pathways into care suggest that this period is characterised by suggest that this period is characterised by contacts with criminal justice services, visits contacts with criminal justice services, visits to accident and emergency departments and to accident and emergency departments and interruptions to employment. All of these interruptions to employment. All of these consequences incur costs, and interventions consequences incur costs, and interventions to reduce the DUP should reduce these, but to reduce the DUP should reduce these, but to date no study has calculated this effect. to date no study has calculated this effect. Further discussion of the DUP is provided Further discussion of the DUP is provided by Singh (2007) in this supplement. by Singh (2007) in this supplement.
Most economic (and clinical) evaluaMost economic (and clinical) evaluations have relatively short time scales. The tions have relatively short time scales. The consequence of this is that the longer-term consequence of this is that the longer-term cost impact of improved, or worsened, outcost impact of improved, or worsened, outcomes is neglected. If an intervention is succomes is neglected. If an intervention is successful then it is highly likely that this will cessful then it is highly likely that this will have a long-term impact on the use and cost have a long-term impact on the use and cost of services, especially for people with a of services, especially for people with a long-term condition such as schizophrenia long-term condition such as schizophrenia where some of the care inputs required where some of the care inputs required have particularly high costs. However, the have particularly high costs. However, the extent of cost savings as a result of successextent of cost savings as a result of successful interventions is unclear. Engagement ful interventions is unclear. Engagement with services might be enhanced, which with services might be enhanced, which could actually increase long-term costs. could actually increase long-term costs. However, it is probably more likely that However, it is probably more likely that effective care will reduce the need for crisis effective care will reduce the need for crisis services -and in particular emergency services -and in particular emergency admissions -if effectiveness means fewer admissions -if effectiveness means fewer and less severe relapses. and less severe relapses.
LINKING COSTS LINKING COSTS TO OUTCOMES TO OUTCOMES
The measurement of costs associated with The measurement of costs associated with interventions for schizophrenia forms only interventions for schizophrenia forms only one component of an economic evaluation. one component of an economic evaluation. The synthesis of information on costs with The synthesis of information on costs with data on effectiveness is the essence of data on effectiveness is the essence of economic evaluation. This is illustrated in economic evaluation. This is illustrated in Fig. 1 where costs (should) depend on pa- Fig. 1 where costs (should) depend on patient needs and influence outcomes. There tient needs and influence outcomes. There are different forms of economic evaluation are different forms of economic evaluation and these differ according to how outcomes and these differ according to how outcomes are measured. are measured.
Cost-minimisation analysis Cost-minimisation analysis
There are some situations where the outThere are some situations where the outcomes of different services are known comes of different services are known a a priori priori, and therefore only costs need to be , and therefore only costs need to be measured. If outcomes are identical then measured. If outcomes are identical then the least-cost option is the preferred one. the least-cost option is the preferred one. However, given the variety of possible However, given the variety of possible interventions for schizophrenia (typical interventions for schizophrenia (typical and atypical antipsychotics, psychological and atypical antipsychotics, psychological therapies, early intervention, etc.) only therapies, early intervention, etc.) only rarely will outcomes be known with confirarely will outcomes be known with confidence beforehand. dence beforehand.
Cost-effectiveness analysis Cost-effectiveness analysis
Cost-effectiveness analysis combines cost inCost-effectiveness analysis combines cost information with data on a single conditionformation with data on a single conditionspecific outcome measure, for example specific outcome measure, for example symptomatology or social functioning. This symptomatology or social functioning. This s 4 3 s 4 3 AUTHOR'S PROOF AUTHOR'S PROOF form of analysis can have particular releform of analysis can have particular relevance for clinicians. However, it is limited vance for clinicians. However, it is limited given that schizophrenia affects patients in given that schizophrenia affects patients in many ways. This is a common limitation many ways. This is a common limitation of most clinical evaluations, which generally of most clinical evaluations, which generally specify a primary outcome measure. specify a primary outcome measure.
Cost^consequences analysis Cost^consequences analysis
This is a more general case of cost-effectiveThis is a more general case of cost-effectiveness analysis that reflects the broad impact ness analysis that reflects the broad impact that interventions have. Rather than one that interventions have. Rather than one single outcome measure being used, a numsingle outcome measure being used, a number of different measures are considered. ber of different measures are considered. Economic evaluations of interventions Economic evaluations of interventions could combine cost-effectiveness and costcould combine cost-effectiveness and costconsequences analyses, with the former consequences analyses, with the former conducted using the primary clinical outconducted using the primary clinical outcome measure and secondary measures simcome measure and secondary measures simply reported alongside the cost findings. ply reported alongside the cost findings.
Cost^utility analysis Cost^utility analysis
This is similar to cost-effectiveness analysis This is similar to cost-effectiveness analysis but uses a generic measure of outcome. but uses a generic measure of outcome. This enables interventions in diverse areas This enables interventions in diverse areas (e.g. cancer and stroke) to be compared in (e.g. cancer and stroke) to be compared in terms of cost-utility with those for schizoterms of cost-utility with those for schizophrenia. The most common outcome phrenia. The most common outcome measure in this form of analysis is the measure in this form of analysis is the quality-adjusted life-year (QALY). Having quality-adjusted life-year (QALY). Having a generic measure of outcome is of particua generic measure of outcome is of particular importance for those making recomlar importance for those making recommendations across diverse clinical areas. mendations across diverse clinical areas. In the UK, NICE bases many of its findings In the UK, NICE bases many of its findings on the cost per QALY achieved by different on the cost per QALY achieved by different interventions. interventions. Quality-adjusted life-years are a compoQuality-adjusted life-years are a composite measure of the amount of time spent in site measure of the amount of time spent in a particular healthcare state and the quality a particular healthcare state and the quality of life experienced during that time. The of life experienced during that time. The latter is measured on a scale from 0 (death) latter is measured on a scale from 0 (death) to 1 (full health). The most common quality to 1 (full health). The most common quality of life measure used in economic evaluations of life measure used in economic evaluations is the EuroQoL-5D (EQ-5D; Williams, is the EuroQoL-5D (EQ-5D; Williams, 1995) . This consists of five domains (mobil-1995) . This consists of five domains (mobility, self-care, usual activities, pain/discomfort ity, self-care, usual activities, pain/discomfort and depression/anxiety) and respondents and depression/anxiety) and respondents state whether they have no problem, some state whether they have no problem, some problems or major problems for each doproblems or major problems for each domain. This results in distinct health states main. This results in distinct health states to which 'utility' or quality of life scores to which 'utility' or quality of life scores (on a 0-1 scale) are attached. Such scores (on a 0-1 scale) are attached. Such scores have been derived from a general popuhave been derived from a general population survey where people were asked to lation survey where people were asked to compare health states with full health compare health states with full health (Dolan (Dolan et al et al, 1995) . , 1995). To date, cost-utility analysis has been To date, cost-utility analysis has been used infrequently in studies of care for used infrequently in studies of care for schizophrenia. Most QALY measures (such schizophrenia. Most QALY measures (such as the EQ-5D) focus largely on physical as the EQ-5D) focus largely on physical health problems and there are questions health problems and there are questions about the sensitivity of QALY measures to about the sensitivity of QALY measures to changes in mental health states (Chisholm changes in mental health states . However, there have been a , 1997). However, there have been a small number of attempts to use the QALY small number of attempts to use the QALY method in studies of schizophrenia care method in studies of schizophrenia care (e.g. Rosenheck (e.g. Rosenheck et al et al, 1998; Sevy , 1998; Sevy et al et al, , 2001 ) and more work in this area would 2001) and more work in this area would be useful. be useful.
Cost^benefit analysis Cost^benefit analysis
Cost-benefit analysis compares the costs of Cost-benefit analysis compares the costs of a particular service with the outcomes a particular service with the outcomes achieved also measured in monetary terms. achieved also measured in monetary terms. If the outcomes in monetary terms exceed If the outcomes in monetary terms exceed the costs then the service is efficient. One the costs then the service is efficient. One of the very earliest economic evaluations of the very earliest economic evaluations of community mental health services in of community mental health services in Madison (Wisconsin, USA) used this Madison (Wisconsin, USA) used this method, with earnings from work used as method, with earnings from work used as the main outcome measure (Weisbrod the main outcome measure (Weisbrod et et al al, 1980) . The breadth of ways in which , 1980). The breadth of ways in which interventions for schizophrenia might affect interventions for schizophrenia might affect patients suggests that cost-benefit analysis patients suggests that cost-benefit analysis will rarely be appropriate. will rarely be appropriate.
ANALYSIS AND ANALYSIS AND INTERPRETATION INTERPRETATION OF ECONOMIC RESULTS OF ECONOMIC RESULTS
If a new intervention for schizophrenia is If a new intervention for schizophrenia is compared with usual care then a number compared with usual care then a number of results could occur. It would be approof results could occur. It would be appropriate to adopt an intervention if it results priate to adopt an intervention if it results in lower costs than existing care and better in lower costs than existing care and better outcomes. The intervention should also be outcomes. The intervention should also be favoured if outcomes are no different but favoured if outcomes are no different but costs are reduced or if costs are the same costs are reduced or if costs are the same and outcomes are improved. Usual care and outcomes are improved. Usual care would be the preferred option if the results would be the preferred option if the results were the opposite way round. However, it were the opposite way round. However, it is unclear whether or not a new intervenis unclear whether or not a new intervention should be adopted if outcomes are tion should be adopted if outcomes are better but costs are higher. In effect this better but costs are higher. In effect this becomes a value judgement, with the key becomes a value judgement, with the key question being whether or not the increased question being whether or not the increased costs are justified by the level of improved costs are justified by the level of improved outcomes. Similarly, there is ambiguity outcomes. Similarly, there is ambiguity about the appropriateness of an intervenabout the appropriateness of an intervention if it saves money but is less effective. tion if it saves money but is less effective. Interestingly, there appear to be few studies Interestingly, there appear to be few studies in this category. Interventions with signifiin this category. Interventions with significantly better outcomes than comparators cantly better outcomes than comparators will frequently reduce costs (especially will frequently reduce costs (especially those associated with admissions). those associated with admissions).
Many economic evaluations actually Many economic evaluations actually have uncertain results. For example, both have uncertain results. For example, both the UK700 study (Byford the UK700 study (Byford et al et al, 2000) and , 2000) and the PRiSM Psychosis Study (McCrone the PRiSM Psychosis Study (McCrone et et al al, 1998) , which compared the costs and , 1998), which compared the costs and outcomes of intensive and standard care outcomes of intensive and standard care services for people with psychosis, found services for people with psychosis, found no statistically significant differences beno statistically significant differences between costs and outcomes. tween costs and outcomes.
To address such uncertainty, it is beTo address such uncertainty, it is becoming common practice to link cost and coming common practice to link cost and outcome data from cost-effectiveness and outcome data from cost-effectiveness and cost-utility analyses using incremental cost-utility analyses using incremental cost-effectiveness ratios (ICERs). An ICER cost-effectiveness ratios (ICERs). An ICER is defined as the ratio between the differis defined as the ratio between the difference in costs between two interventions ence in costs between two interventions and the difference in outcomes. The ICER and the difference in outcomes. The ICER then allows us to state the cost that is inthen allows us to state the cost that is incurred for an intervention to produce one curred for an intervention to produce one unit of outcome more than a comparator. unit of outcome more than a comparator. An ICER is only informative if one interAn ICER is only informative if one intervention is both more effective and more vention is both more effective and more costly than its comparator (otherwise the costly than its comparator (otherwise the intervention or the comparator would be intervention or the comparator would be the dominant option). Relating incremental the dominant option). Relating incremental costs to incremental outcomes suggests that costs to incremental outcomes suggests that a unit improvement in outcome (e.g. a 1-a unit improvement in outcome (e.g. a 1-point decrease in score on the Brief Psypoint decrease in score on the Brief Psychiatric Rating Scale or the Positive and chiatric Rating Scale or the Positive and Negative Syndrome Scale) has a meaning Negative Syndrome Scale) has a meaning to decision makers. The latter may not hold to decision makers. The latter may not hold and so more tangible outcome measures and so more tangible outcome measures might be preferred (e.g. measuring outcome might be preferred (e.g. measuring outcome in terms of number of clinically important in terms of number of clinically important changes or number of people above or changes or number of people above or below a particular clinical cut-off point). below a particular clinical cut-off point).
One of the problems with ICERs is that One of the problems with ICERs is that they rely on point estimates of costs and they rely on point estimates of costs and outcomes and yet there will be uncertainty outcomes and yet there will be uncertainty around both of these. This has led around both of these. This has led economists to produce cost-effectiveness economists to produce cost-effectiveness acceptability curves. These show the acceptability curves. These show the probability that one intervention is more probability that one intervention is more cost-effective than another for alternative cost-effective than another for alternative values (thresholds) placed on a unit values (thresholds) placed on a unit improvement in outcome. improvement in outcome.
CONCLUSIONS CONCLUSIONS
Since the 1980s there has been a substantial Since the 1980s there has been a substantial increase in the number of studies that increase in the number of studies that have examined the costs associated with have examined the costs associated with s 4 4 s 4 4 AUTHOR'S PROOF AUTHOR'S PROOF schizophrenia and economic evaluations of schizophrenia and economic evaluations of specific interventions for this disorder. The specific interventions for this disorder. The quality of studies has generally improved quality of studies has generally improved but there are still limitations. In particular, but there are still limitations. In particular, recent methodological developments in recent methodological developments in health economics generally need to be health economics generally need to be applied to multi-site studies to generate eviapplied to multi-site studies to generate evidence from the large samples that these studence from the large samples that these studies can provide. Schizophrenia affects the dies can provide. Schizophrenia affects the lives of patients in many ways and it is lives of patients in many ways and it is essential that outcome measures used in essential that outcome measures used in economic evaluations reflect this. What is economic evaluations reflect this. What is clear is that the costs of care should be clear is that the costs of care should be measured comprehensively and over an measured comprehensively and over an adequate period. Costs also need to be adequate period. Costs also need to be linked to outcomes appropriately. The most linked to outcomes appropriately. The most suitable methods for doing this appear to be suitable methods for doing this appear to be cost-effectiveness and cost-utility analyses. cost-effectiveness and cost-utility analyses.
